Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib March 10, 2018 admin CEO Interview, Healthcare Comments Off on Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Did you enjoy this article? Join our FREE Newsletter! Thank you for subscribing. Something went wrong. I agree to have my personal information transfered to MailChimp ( more information ) Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd. We hate spam. Your email address will not be sold or shared with anyone else.